Lomotil Schedule Classification
Lomotil (diphenoxylate with atropine) is classified as a Schedule V controlled substance by federal regulation. 1, 2
Regulatory Classification Details
The Drug Enforcement Administration (DEA) has designated Lomotil as Schedule V under the Comprehensive Drug Abuse Prevention and Control Act of 1970. This classification reflects:
- Lower abuse potential compared to Schedule II-IV substances
- Limited physical or psychological dependence risk at therapeutic doses
- Accepted medical use for treatment of diarrhea
Why Schedule V?
The combination formulation includes:
- Diphenoxylate hydrochloride (2.5 mg per tablet) - an opioid chemically related to meperidine 1
- Atropine sulfate (0.025 mg per tablet) - added in subtherapeutic amounts specifically to discourage deliberate overdosage 1
The atropine component serves as a deterrent to abuse by causing unpleasant anticholinergic effects (dry mouth, blurred vision, urinary retention) if taken in excessive amounts, making recreational use less appealing.
Abuse Potential Considerations
At therapeutic doses for diarrhea treatment:
- Diphenoxylate is devoid of morphine-like subjective effects 1, 2
- The antidiarrheal dose is widely separated from doses causing CNS effects 1
- The drug's insolubility in aqueous media precludes intravenous self-administration 1
However, at high doses (100-300 mg/day, equivalent to 40-120 tablets), diphenoxylate exhibits codeine-like effects and can produce opiate withdrawal symptoms after prolonged use 1, 2. This abuse potential, though present at supratherapeutic doses, justifies controlled substance classification while recognizing the lower risk compared to higher schedule opioids.
Clinical Context
For comparison, other commonly prescribed opioids have different schedules 3:
- Schedule II: Morphine, oxycodone, hydromorphone, single-entity oxycodone products
- Schedule III: Hydrocodone combination products (e.g., Vicodin), codeine combinations
- Schedule V: Lomotil, certain low-dose codeine preparations
The Schedule V classification means Lomotil requires a prescription in most jurisdictions but has less stringent regulatory controls than higher schedule substances.